FDA Adverse Event Malfunction Summary report: N

POWERFLEX PRO PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY CATHETER

MDR report key: 2983241 · Received February 28, 2013

Report

Report Number
9616099-2013-00103
Event Type
Malfunction
Date Received
February 28, 2013
Date of Event
January 28, 2013
Report Date
February 8, 2013
Manufacturer
CORDIS DE MEXICO
Product Code
DQY
PMA / PMN Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NL
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE PRODUCT WAS RETURNED FOR EVALUATION AND TESTING; HOWEVER, THE ENGINEERING EVALUATION IS NOT COMPLETE. ADDITIONAL INFORMATION WILL BE SUBMITTED WITHIN 30 DAYS UPON RECEIPT. THIS IS ONE OF THREE PRODUCTS USED DURING THE SAME PROCEDURE. PLEASE REFERENCE MFR. REPORT # 9616099-2013-00102, # 9616099-2013-00103, AND # 9616099-2013-00104.

Additional Manufacturer Narrative · 1

PLEASE NOTE THAT ADDITIONAL INFORMATION RECEIVED INDICATED THAT THE THREE (3) DEVICES/PI'S INCLUDED IN THIS FILE/SR WERE USED IN THREE (3) DIFFERENT PATIENT'S/CASES. AS SUCH, THIS PI WILL BE VOIDED. THE PRODUCT REPORTED UNDER THIS PI/REPORT WILL BE CAPTURED UNDER (B)(4). NO ADDITIONAL INFORMATION WILL BE FORTHCOMING.

Description of Event or Problem · 1

THE REPORT RECEIVED FROM THE AFFILIATE INDICATED THAT THE THREE (3 EACH) 80 CM. POWERFLEX PRO 7 MM. X 4 CM. BALLOON CATHETERS USED DURING THE PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY/PTA OF A DIALYSIS SHUNT TARGET LESION WERE DIFFICULT TO WITHDRAW THROUGH THE SHEATH. IT WAS REPORTED THAT AFTER DEFLATION OF THE DEVICES UNDER VACUUM WITH AN INDEFLATOR, THE BALLOONS BECAME STOCKED PRIOR TO ENTERING THE SHEATH USED. THE PHYSICIAN WAS ABLE TO WITHDRAW THE CATHETERS THROUGH THE SHEATH USING FORCE. THERE WAS NO REPORTED PATIENT INJURY. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
88349 POWERFLEX PRO PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY CATHETER PTA CATHETERS DQY CORDIS DE MEXICO NA 15705790

Patients

Seq Age Sex Outcome Treatment
1 TERUMO G/W .035